American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Рекомендации Американской коллегии ревматологов 2012 года по применению немедикаментозной и медикаментозной терапии при остеоартрите кистей, тазобедренных и коленных суставов
2012-01-09
SCID: 54.1/a4dahmqt
Discuss with AI
ACR recommendationsGRADE approachnonpharmacologic therapiesosteoarthritispharmacologic therapies
Figures from the paper
Abstract (AI)
OBJECTIVE: To update the American College of Rheumatology (ACR) 2000 recommendations for hip and knee osteoarthritis (OA) and develop new recommendations for hand OA. METHODS: A list of pharmacologic and nonpharmacologic modalities commonly used to manage knee, hip, and hand OA as well as clinical scenarios representing patients with symptomatic hand, hip, and knee OA were generated. Systematic evidence-based literature reviews were conducted by a working group at the Institute of Population Health, University of Ottawa, and updated by ACR staff to include additions to bibliographic databases through December 31, 2010. The Grading of Recommendations Assessment, Development and Evaluation approach, a formal process to rate scientific evidence and to develop recommendations that are as evidence based as possible, was used by a Technical Expert Panel comprised of various stakeholders to formulate the recommendations for the use of nonpharmacologic and pharmacologic modalities for OA of the hand, hip, and knee. RESULTS: Both “strong” and “conditional” recommendations were made for OA management. Modalities conditionally recommended for the management of hand OA include instruction in joint protection techniques, provision of assistive devices, use of thermal modalities and trapeziometacarpal joint splints, and use of oral and topical nonsteroidal antiinflammatory drugs (NSAIDs), tramadol, and topical capsaicin. Nonpharmacologic modalities strongly recommended for the management of knee OA were aerobic, aquatic, and/or resistance exercises as well as weight loss for overweight patients. Nonpharmacologic modalities conditionally recommended for knee OA included medial wedge insoles for valgus knee OA, subtalar strapped lateral insoles for varus knee OA, medially directed patellar taping, manual therapy, walking aids, thermal agents, tai chi, self management programs, and psychosocial interventions. Pharmacologic modalities conditionally recommended for the initial management of patients with knee OA included acetaminophen, oral and topical NSAIDs, tramadol, and intraarticular corticosteroid injections; intraarticular hyaluronate injections, duloxetine, and opioids were conditionally recommended in patients who had an inadequate response to initial therapy. Opioid analgesics were strongly recommended in patients who were either not willing to undergo or had contraindications for total joint arthroplasty after having failed medical therapy. Recommendations for hip OA were similar to those for the management of knee OA. CONCLUSION: These recommendations are based on the consensus judgment of clinical experts from a wide range of disciplines, informed by available evidence, balancing the benefits and harms of both nonpharmacologic and pharmacologic modalities, and incorporating their preferences and values. It is hoped that these recommendations will be utilized by health care providers involved in the management of patients with OA.
Key Findings
1
Conditional knee osteoarthritis recommendations include selected insoles, patellar taping, manual therapy, walking aids, thermal agents, tai chi, self-management, and psychosocial interventions.
2
Conditional recommendations for hand osteoarthritis include joint-protection education, assistive devices, thermal modalities, trapeziometacarpal splints, NSAIDs, tramadol, and topical capsaicin.
3
Recommendations were developed through systematic evidence reviews and the GRADE framework, incorporating stakeholder expertise and literature through December 31, 2010.
4
Strong recommendations for knee osteoarthritis include aerobic, aquatic, or resistance exercise and weight loss for overweight patients.
5
The paper updates the ACR 2000 recommendations for hip and knee osteoarthritis and introduces recommendations for hand osteoarthritis.
Research Object
Nonpharmacologic and pharmacologic therapies for osteoarthritis of the hand, hip, and knee
Research Subject
Evidence-based recommendations for the use of nonpharmacologic and pharmacologic therapies
Publication Details
Publication Date
2012-01-09
Journal
Publisher
ISSN
Cited by
3135
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by12
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 20162016
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee2020
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee2020
Osteoarthritis: pathogenic signaling pathways and therapeutic targets2023
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)2019
Knee osteoarthritis: pathophysiology and current treatment modalities2018
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)2014
What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?2014
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)2017
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis2019
Access to Highly Purified Chondroitin Sulfate for Appropriate Treatment of Osteoarthritis: A Review2017
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis2018